Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...
Researchers from the National University of Singapore (NUS) have recently achieved a significant breakthrough in the ...
As movie theaters worked to entice Americans back into seats after COVID-19 lockdowns and labor strikes, the industry ...
Cal Poly faces UC San Diego. Our college basketball odds series has our Cal Poly UC San Diego prediction, odds and pick for ...
Trump claimed on social media Wednesday that President Joe Biden is leaving him “NO MONEY IN FEMA.” ...
The Lake Minnetonka Klondike Dog Derby announced Thursday that a lack of snow on Lake Minnetonka will again cancel the race, ...
The Phase III trial successfully saw patients achieving clinical remission and stopping rectal bleeding within 28 days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback